Revised advertising guidelines GPs need to know The updated AHPRA resource is designed to protect the public from false or misleading claims and allow them to make informed healthcare choices.
Mundipharma fined for misleading advertising of opioids The international affiliate of Purdue Pharma was issued 24 infringement notices by the Therapeutic Goods Administration.
TGA changes offer greater protection from misleading advertising The TGA intends its updated code to provide consumers improved protection from misleading advertising of therapeutic goods.
AHPRA releases further guidance on the use of testimonials Health organisations and individual practitioners should be aware that selectively editing reviews or testimonials can potentially break the law, the Australian Health Practitioner Regulation Agency has warned.
Ban on direct-to-consumer advertising by after-hours providers welcomed by RACGP RACGP President Dr Bastian Seidel told newsGP he is pleased with the news after-hours primary care services would no longer be allowed to employ direct-to-consumer advertising.
Advertising: Is your practice compliant? The Australian Health Practitioner Regulation Agency (AHPRA) recently starting sending letters to practitioners as part of its advertising compliance and enforcement strategy.